189 related articles for article (PubMed ID: 22771891)
1. 4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition.
Riedel TJ; Knight J; Murray MS; Milliner DS; Holmes RP; Lowther WT
Biochim Biophys Acta; 2012 Oct; 1822(10):1544-52. PubMed ID: 22771891
[TBL] [Abstract][Full Text] [Related]
2. Structural and biochemical studies of human 4-hydroxy-2-oxoglutarate aldolase: implications for hydroxyproline metabolism in primary hyperoxaluria.
Riedel TJ; Johnson LC; Knight J; Hantgan RR; Holmes RP; Lowther WT
PLoS One; 2011; 6(10):e26021. PubMed ID: 21998747
[TBL] [Abstract][Full Text] [Related]
3. Regulation of human 4-hydroxy-2-oxoglutarate aldolase by pyruvate and α-ketoglutarate: implications for primary hyperoxaluria type-3.
Huang A; Burke J; Bunker RD; Mok YF; Griffin MD; Baker EN; Loomes KM
Biochem J; 2019 Nov; 476(21):3369-3383. PubMed ID: 31696211
[TBL] [Abstract][Full Text] [Related]
4. Primary hyperoxaluria type III--a model for studying perturbations in glyoxylate metabolism.
Belostotsky R; Pitt JJ; Frishberg Y
J Mol Med (Berl); 2012 Dec; 90(12):1497-504. PubMed ID: 22729392
[TBL] [Abstract][Full Text] [Related]
5. Nine novel HOGA1 gene mutations identified in primary hyperoxaluria type 3 and distinct clinical and biochemical characteristics in Chinese children.
Fang X; He L; Xu G; Lin H; Xu M; Geng H
Pediatr Nephrol; 2019 Oct; 34(10):1785-1790. PubMed ID: 31123811
[TBL] [Abstract][Full Text] [Related]
6. Updated genetic testing of Italian patients referred with a clinical diagnosis of primary hyperoxaluria.
Pelle A; Cuccurullo A; Mancini C; Sebastiano R; Stallone G; Negrisolo S; Benetti E; Peruzzi L; Petrarulo M; De Marchi M; Marangella M; Amoroso A; Giachino D; Mandrile G
J Nephrol; 2017 Apr; 30(2):219-225. PubMed ID: 26946417
[TBL] [Abstract][Full Text] [Related]
7. Cellular degradation of 4-hydroxy-2-oxoglutarate aldolase leads to absolute deficiency in primary hyperoxaluria type 3.
MacDonald JR; Huang AD; Loomes KM
FEBS Lett; 2016 May; 590(10):1467-76. PubMed ID: 27096395
[TBL] [Abstract][Full Text] [Related]
8. Mutation Hot Spot Region in the HOGA1 Gene Associated with Primary Hyperoxaluria Type 3 in the Chinese Population.
Wang W; Liu Y; Kang L; He R; Song J; Li Y; Li J; Yang Y
Kidney Blood Press Res; 2019; 44(4):743-753. PubMed ID: 31401635
[TBL] [Abstract][Full Text] [Related]
9. Mutations in DHDPSL are responsible for primary hyperoxaluria type III.
Belostotsky R; Seboun E; Idelson GH; Milliner DS; Becker-Cohen R; Rinat C; Monico CG; Feinstein S; Ben-Shalom E; Magen D; Weissman I; Charon C; Frishberg Y
Am J Hum Genet; 2010 Sep; 87(3):392-9. PubMed ID: 20797690
[TBL] [Abstract][Full Text] [Related]
10. Renal function can be impaired in children with primary hyperoxaluria type 3.
Allard L; Cochat P; Leclerc AL; Cachat F; Fichtner C; De Souza VC; Garcia CD; Camoin-Schweitzer MC; Macher MA; Acquaviva-Bourdain C; Bacchetta J
Pediatr Nephrol; 2015 Oct; 30(10):1807-13. PubMed ID: 25972204
[TBL] [Abstract][Full Text] [Related]
11. The enzyme 4-hydroxy-2-oxoglutarate aldolase is deficient in primary hyperoxaluria type III.
Hoppe B
Nephrol Dial Transplant; 2012 Aug; 27(8):3024-6. PubMed ID: 22851625
[No Abstract] [Full Text] [Related]
12. Use of a novel microtitration protocol to obtain diffraction-quality crystals of 4-hydroxy-2-oxoglutarate aldolase from Bos taurus.
Huang A; Baker E; Loomes K
Acta Crystallogr F Struct Biol Commun; 2014 Nov; 70(Pt 11):1546-9. PubMed ID: 25372828
[TBL] [Abstract][Full Text] [Related]
13. The effects of the inactivation of Hydroxyproline dehydrogenase on urinary oxalate and glycolate excretion in mouse models of primary hyperoxaluria.
Buchalski B; Wood KD; Challa A; Fargue S; Holmes RP; Lowther WT; Knight J
Biochim Biophys Acta Mol Basis Dis; 2020 Mar; 1866(3):165633. PubMed ID: 31821850
[TBL] [Abstract][Full Text] [Related]
14. Metabolism of (13)C5-hydroxyproline in mouse models of Primary Hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase.
Li X; Knight J; Fargue S; Buchalski B; Guan Z; Inscho EW; Liebow A; Fitzgerald K; Querbes W; Todd Lowther W; Holmes RP
Biochim Biophys Acta; 2016 Feb; 1862(2):233-9. PubMed ID: 26655602
[TBL] [Abstract][Full Text] [Related]
15. Comparative and developmental studies on 4-hydroxy-2-oxoglutarate aldolase and hydroxyproline oxidase.
Carnie JA; Rowsell EV; Dabbaghian MK; Hobbs DR; Rowsell KV
Comp Biochem Physiol B; 1982; 71(4):681-7. PubMed ID: 7083820
[TBL] [Abstract][Full Text] [Related]
16. Mitochondrial hydroxyproline metabolism: implications for primary hyperoxaluria.
Knight J; Holmes RP
Am J Nephrol; 2005; 25(2):171-5. PubMed ID: 15849464
[TBL] [Abstract][Full Text] [Related]
17. Folding Defects Leading to Primary Hyperoxaluria.
Oppici E; Dindo M; Conter C; Borri Voltattorni C; Cellini B
Handb Exp Pharmacol; 2018; 245():313-343. PubMed ID: 29071511
[TBL] [Abstract][Full Text] [Related]
18. Primary Hyperoxaluria Type 3 Can Also Result in Kidney Failure: A Case Report.
Singh P; Granberg CF; Harris PC; Lieske JC; Licht JH; Weiss A; Milliner DS
Am J Kidney Dis; 2022 Jan; 79(1):125-128. PubMed ID: 34245816
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of the glyoxylate reductase (GRHPR) gene and description of mutations underlying primary hyperoxaluria type 2.
Cregeen DP; Williams EL; Hulton S; Rumsby G
Hum Mutat; 2003 Dec; 22(6):497. PubMed ID: 14635115
[TBL] [Abstract][Full Text] [Related]
20. Metabolite diagnosis of primary hyperoxaluria type 3.
Greed L; Willis F; Johnstone L; Teo S; Belostotsky R; Frishberg Y; Pitt J
Pediatr Nephrol; 2018 Aug; 33(8):1443-1446. PubMed ID: 29705963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
